FDA also asked the committees to agree on the lowest acceptable rate of cure that is meaningful for a topical OTC drug product for the treatment of tinea pedis. The committee focused on what the ...
The global tinea pedis treatment market is on track for substantial growth, with projections indicating a rise from USD 1,496.3 million in 2024 to USD 2,484 million by 2034. This growth represents a ...